APT MEDICAL INC - Financials

APT MEDICAL INC — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017
+Revenue	2.1B	1.6B	1.2B	829.0M	479.0M	404.0M	242.0M	153.0M
Revenue Growth %	25.2%	35.7%	46.7%	73.1%	18.6%	66.9%	58.2%	--
Total Revenue	2.1B	1.6B	1.2B	829.0M	479.0M	404.0M	242.0M	153.0M
Cost Of Revenue	572.0M	474.0M	350.0M	253.0M	142.0M	118.0M	75.5M	47.8M
+Gross Profit	1.5B	1.2B	866.0M	576.0M	337.0M	286.0M	166.5M	105.2M
Gross Margin %	72.3%	71.3%	71.2%	69.5%	70.4%	70.8%	68.8%	68.8%
Total Operating Cost	1.4B	1.1B	860.0M	658.0M	375.0M	316.0M	224.0M	146.0M
Selling Expenses	373.0M	305.0M	241.0M	196.0M	114.0M	89.0M	70.5M	25.3M
Admin Expenses	91.5M	82.3M	66.5M	55.1M	39.6M	33.0M	22.2M	17.5M
Rd Expenses	291.0M	238.0M	175.0M	135.0M	71.9M	70.4M	53.4M	50.0M
Finance Expenses	-12.5M	-3.3M	-2.7M	641,600	201,300	80,400	-551,000	542,900
+Operating Income	754.0M	600.0M	397.0M	223.0M	119.0M	92.1M	23.6M	31.1M
Operating Margin %	36.5%	36.4%	32.6%	26.9%	24.8%	22.8%	9.8%	20.3%
Non Operating Income	281,900	620,900	1.6M	43,300	2.0M	8,200	10,600	31,600
Non Operating Expenses	8.0M	4.7M	3.4M	992,200	250,200	746,700	400,000	156,900
Investment Income	13.2M	23.1M	20.7M	11.1M	-67,700	-1.0M	282,500	18.6M
Fair Value Change Income	--	--	341,800	21.7M	--	--	--	--
Asset Disposal Income	253,300	12.0M	56,200	16,600	300.00	-900.00	39,800	-3,800
Asset Impairment Loss	24.6M	15.8M	14.5M	9.7M	6,900	272,000	-84,900	2.8M
Other Income	40.8M	46.4M	19.4M	18.8M	14.9M	5.3M	5.6M	5.5M
Income Before Tax	746.0M	596.0M	395.0M	222.0M	121.0M	91.4M	23.2M	31.0M
Income Tax	87.8M	74.2M	55.0M	26.7M	17.0M	13.3M	6.5M	3.9M
+Net Income	658.0M	522.0M	340.0M	195.0M	104.0M	78.1M	16.7M	27.1M
Net Margin %	31.8%	31.6%	28.0%	23.5%	21.7%	19.3%	6.9%	17.7%
Net Income Attributable	673.0M	534.0M	358.0M	208.0M	111.0M	82.6M	21.5M	34.5M
Minority Interest	-15.0M	-11.8M	-17.9M	-13.1M	-6.6M	-4.5M	-4.8M	-7.4M
Eps Basic	6.96	5.54	5.38	3.19	2.22	1.65	0.43	0.69
Eps Diluted	6.92	5.46	5.30	3.17	2.22	1.65	0.43	0.69

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017
Cash And Equivalents	1.1B	1.3B	251.0M	310.0M	120.0M	73.5M	90.8M	79.4M
Trading Financial Assets	--	60.0M	881.0M	914.0M	--	--	--	--
Accounts Receivable	83.3M	41.4M	47.2M	34.0M	43.7M	47.1M	25.4M	30.0M
Notes Receivable	--	362,100	--	--	--	--	--	--
Notes And Accounts Receivable	83.3M	41.8M	47.2M	34.0M	43.7M	47.1M	25.4M	30.0M
Prepayments	32.3M	38.1M	25.4M	19.1M	9.3M	6.3M	4.6M	2.8M
Inventory	399.0M	328.0M	338.0M	263.0M	145.0M	143.0M	80.4M	43.8M
Total Current Assets	1.6B	1.8B	1.6B	1.6B	350.0M	274.0M	207.0M	160.0M
Long Term Equity Investment	101.0M	38.7M	67.3M	45.0M	12.8M	13.1M	12.8M	15.0M
Fixed Assets	--	399.0M	292.0M	208.0M	137.0M	112.0M	--	--
Fixed Assets Total	615.0M	399.0M	292.0M	208.0M	137.0M	112.0M	93.3M	61.3M
Construction In Progress	--	47.8M	15.0M	37.2M	17.6M	21.8M	--	--
Construction In Progress Total	46.3M	47.8M	15.0M	37.3M	17.6M	21.8M	7.4M	8.0M
Intangible Assets	402.0M	83.0M	38.9M	32.4M	32.5M	104.0M	1.0M	1.1M
Long Term Deferred Expenses	3.4M	6.0M	5.1M	7.4M	1.6M	1.1M	587,000	921,500
Total Non Current Assets	1.4B	817.0M	669.0M	460.0M	238.0M	287.0M	119.0M	92.9M
Total Assets	3.0B	2.6B	2.2B	2.0B	589.0M	561.0M	326.0M	253.0M
Short Term Borrowings	--	70.0M	30.0M	16.0M	10.5M	33.8M	10.5M	1.0M
Accounts Payable	46.3M	42.7M	41.2M	21.1M	8.4M	11.0M	6.8M	6.0M
Advance Receipts	--	--	--	--	--	4.1M	3.4M	4.4M
Contract Liabilities	45.4M	44.4M	38.2M	32.3M	16.7M	--	--	--
Total Current Liabilities	406.0M	588.0M	412.0M	195.0M	109.0M	101.0M	48.5M	33.8M
Long Term Borrowings	--	591,000	1.8M	10.2M	23.6M	104.0M	--	--
Total Non Current Liabilities	19.9M	22.8M	23.0M	27.5M	29.2M	114.0M	6.6M	4.5M
Total Liabilities	426.0M	611.0M	435.0M	222.0M	139.0M	215.0M	55.1M	38.3M
Paid In Capital	97.4M	66.9M	66.7M	66.7M	50.0M	50.0M	29.4M	29.4M
Capital Reserve	785.0M	724.0M	1.0B	1.3B	159.0M	159.0M	109.0M	74.6M
Surplus Reserve	48.7M	33.4M	30.8M	20.2M	12.0M	384,800	10.2M	10.2M
Retained Earnings	1.6B	1.1B	686.0M	405.0M	239.0M	140.0M	121.0M	100.0M
Minority Equity	38.5M	54.9M	27.8M	13.0M	-10.3M	-3.7M	857,200	251,100
Equity Attributable	2.5B	1.9B	1.8B	1.8B	460.0M	350.0M	270.0M	214.0M
Total Equity	2.6B	2.0B	1.8B	1.8B	450.0M	346.0M	271.0M	214.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017
Cash From Sales	2.3B	1.8B	1.3B	963.0M	551.0M	428.0M	280.0M	179.0M
Tax Refunds Received	7.1M	6.9M	4.5M	4.0M	3.4M	3.2M	2.3M	3.4M
Total Operating Cash Inflow	2.3B	1.9B	1.4B	989.0M	569.0M	443.0M	291.0M	187.0M
Cash Paid For Goods	445.0M	330.0M	307.0M	328.0M	116.0M	153.0M	112.0M	54.9M
Cash Paid To Employees	545.0M	423.0M	338.0M	233.0M	139.0M	109.0M	73.3M	57.0M
Taxes Paid	258.0M	211.0M	151.0M	82.3M	56.0M	37.6M	28.7M	18.4M
Total Operating Cash Outflow	1.6B	1.2B	997.0M	808.0M	421.0M	388.0M	273.0M	174.0M
Operating Cash Flow	743.0M	689.0M	367.0M	181.0M	148.0M	54.9M	18.6M	12.9M
Total Investing Cash Inflow	2.5B	1.5B	1.8B	373.0M	88.9M	22.5M	61.0M	22.5M
Total Investing Cash Outflow	3.1B	887.0M	1.9B	1.5B	88.2M	90.6M	89.6M	44.9M
Investing Cash Flow	-618.0M	582.0M	-135.0M	-1.1B	730,100	-68.0M	-28.6M	-22.5M
Cash From Borrowings	--	70.0M	82.6M	23.5M	16.4M	41.5M	15.0M	1.0M
Dividends And Interest Paid	134.0M	112.0M	69.0M	33.2M	1.4M	6.0M	268,300	461,200
Debt Repayments	71.2M	40.3M	75.9M	30.3M	115.0M	13.2M	5.5M	11.3M
Total Financing Cash Inflow	91.0M	105.0M	102.0M	1.2B	16.4M	41.5M	26.7M	12.0M
Total Financing Cash Outflow	399.0M	351.0M	396.0M	128.0M	118.0M	44.7M	5.8M	11.7M
Financing Cash Flow	-308.0M	-246.0M	-295.0M	1.1B	-102.0M	-3.2M	20.9M	258,800
Net Change In Cash	-195.0M	1.0B	-60.7M	189.0M	46.8M	-17.2M	11.4M	-9.9M
Ending Cash Balance	1.1B	1.3B	249.0M	310.0M	120.0M	73.5M	90.8M	79.4M
Capex	650.0M	202.0M	143.0M	167.0M	44.2M	67.6M	32.2M	25.3M